![]() |
市場調査レポート
商品コード
1433401
瞳孔計の世界市場:2023-2030年Global Pupillometer Market 2023-2030 |
||||||
カスタマイズ可能
|
瞳孔計の世界市場:2023-2030年 |
出版日: 2023年12月20日
発行: Orion Market Research
ページ情報: 英文 200 Pages
納期: 2~3営業日
|
世界の瞳孔計市場は予測期間(2023-2030年)にCAGR 6.9%で成長すると予測されます。市場の成長は、世界中のヘルスケアにおける需要の増加に起因しています。ヘルスケアでは、特に眼科、神経科、クリティカルケアなどの分野で、信頼性が高く効率的な診断ツールへの需要が高まっています。瞳孔計は、神経疾患、脳外傷の診断、重篤な患者のモニタリングに不可欠です。例えば、2020年8月、トプコンヘルスケアは新製品Aladdin-Mを発表しました。Aladdin-Mは角膜トポグラフィー、瞳孔計測、光学生体計測を統合し、角膜曲率、瞳孔動態、軸長メトリクスを確実に評価します。
アプリケーションの中で、神経学サブセグメントが世界の瞳孔計市場でかなりのシェアを占めると予想されています。このセグメントの成長は、神経疾患の増加に起因しています。神経疾患や外傷性脳損傷の有病率の上昇は、迅速な検査や治療を実行するために瞳孔計のような正確な診断機器の活用を必要としています。NeurOpticsは2021年2月、瞳孔計教育シンポジウムのプラットフォームを立ち上げました。このプラットフォームでは、神経障害のリスクがある患者の評価とスクリーニングにおいて瞳孔計と神経学的瞳孔指数(NPi)が果たす重要な役割を実証する、製品と臨床の両方に焦点を当てたプレゼンテーションのシリーズが含まれます。
世界の瞳孔計市場は、北米(米国、カナダ)、欧州(英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域)、アジア太平洋地域(インド、中国、日本、韓国、その他アジア地域)、世界のその他の地域(中東とアフリカ、ラテンアメリカ)を含む地域別にさらに細分化されています。中でも、アジア太平洋地域は、様々なウェブサイトやベンダーを通じて瞳孔計の入手可能性が高まっていることから、世界市場で突出したシェアを占めると予測されており、市場拡大の原動力となると予測されています。
すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。地域の成長は、地域全体の臨床需要の増加に起因しています。X線検査指標と神経疾患との間の潜在的な関連性を明らかにするデータは、正確な診断方法の重要性を強調しています。瞳孔反応性を独立して定量化できる瞳孔計は、IPHや虚血性脳卒中などの疾患の神経学的検査でますます有用性を増しています。2022年12月の国立医薬品食品衛生研究所(gov.)によると、74枚のCT画像を有する53人の患者のうち、調査によるところ、49.1%が女性で、年齢の中央値は67歳でした。IPH患者は虚血性脳卒中患者に比べてMLS-SPとPGSが大きく、それぞれ6.2mm対4.0mm、5.6mm対3.4mmでした。この研究では、瞳孔反応性とX線シフトマーカーとの間に有意な関連は認められなかったが、IPHと虚血性脳卒中のコホートでは、MLS-SPとDiff NPiとの間に潜在的な関連が認められました。このことから、正中線シフトと瞳孔反応性の非対称性との関連は、IPHと虚血性脳卒中とで異なることが示唆され、さらなる前向き研究の必要性が強調されました。
Global Pupillometer Market Size, Share & Trends Analysis Report by Type (Digital, and Video), by Application (Ophthalmology, Neurology, Oncology, and Others) and by End User (Hospitals, Eye Clinics, and Others), Forecast Period (2023-2030)
The global pupillometer market is anticipated to grow at a CAGR of 6.9% during the forecast period (2023-2030). The market's growth is attributed to the growing demand in healthcare across the globe. In healthcare, it contains an increasing demand for reliable and efficient diagnostic tools, particularly in sectors such as ophthalmology, neurology, and critical care. The pupillometers are essential in diagnosing neurological diseases, brain traumas, and monitoring patients in critical care situations. For instance, in Augut 2020, Topcon Healthcare launched its new Aladdin-M instrument. Aladdin-M integrates corneal topography, pupillometry, and optical biometry to assess corneal curvature, pupil dynamics, and axial length metrics reliably.
The global pupillometer market is segmented on the type, application, and end user. Based on the type, the market is sub-segmented into digital, and video. Based on the application, the market is sub-segmented into ophthalmology, neurology, oncology, and others. Furthermore, on the basis of end user, the market is sub-segmented into hospitals, eye clinics, and others. The ophthalmology subcategory is expected to capture a significant portion of the market share within the application segment. The growth can be attributed to the demand for precision in eye surgeries is driven by the requirement for accurate measurements and meticulous planning in refractive surgeries and cataract procedures. This has led to an increased interest in systems such as, SeeNa, that aid surgeons in achieving the optimal surgical outcomes possible. For instance, in October 2023, Bausch + Lomb Corp. launched the SeeNa optical biometry and topography system for refractive cataract patients.
Among the application, the neurology sub-segment is expected to hold a considerable share of the global Pupillometer market. The segmental growth is attributed to the increasing neurological disorders. The rising prevalence of neurological conditions and traumatic brain injuries needs for the utilization of precise diagnostic equipment such as pupillometers to perform prompt examinations and therapies. For instane, in February 2021, NeurOptics launched Pupillometry Education Symposiums platform, that includes a series of both product and clinical-focused presentations that demonstrate the essential role pupillometry and the neurological pupil index (NPi) play in the assessment and screening of patients at risk of neurological injury.
The global pupillometer market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the increasing availability of pupillometers in the region via a range of websites and vendors is projected to drive market expansion.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the increasing clinical demand across the region. The data revealing potential associations between radiographic indicators and neurological disorders underscore the importance of precise diagnosis methods. Pupillometers, that can independently quantify pupil responsiveness, have been increasingly useful in neurological examinations for disorders such as IPH and ischemic stroke. According to the National Institute of health (gov.) in December 2022, as per the study among the 53 patients with 74 CT images, 49.1% were female, with a median age of 67 years. The patients with IPH showed greater MLS-SP and PGS compared to patients with ischemic stroke, with measurements of 6.2 mm versus 4.0 mm and 5.6 mm versus 3.4 mm, respectively. The study found no significant association between pupil reactivity and radiographic shift markers, but potential relationships were found between MLS-SP and Diff NPi in the IPH and ischemic stroke cohorts. This suggests that the connection between midline shift and asymmetric pupil reactivity varies between IPH and ischemic stroke, emphasizing the need for additional prospective research.
The major companies serving the pupillometer market includes HAMAMATSU Group, HEINE Optotechnik GmbH & Co. KG, Johnson & Johnson Vision Care, Inc., KARL STORZ, Konan Medical USA Inc. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2021,NeurOptics, launched NPi-300 Pupillometer in the US. The NPi-300 Pupillometer is a versatile tool for neurological examination in both adults and pediatric patients, covering a wide range of diagnoses such as traumatic brain injury, stroke, seizure, and other medical conditions.